PPARA and metabolic dysfunction-associated steatotic liver disease: Indeed, butyrate can reverse PPAR-α activation to enhance FA β-oxidation, inhibit lipid synthesis, and deplete the level of nuclear factor-kappa B (61, 62), which was also observed in NAFLD-OVX mice (50).